About Us – GeneousAdvisors

GeneousAILeadership Team

https://gen-ad.academysmart.com/wp-content/uploads/2025/11/6O6A3602-Edit2-top-shot-4.png

Keith Ryan

Drawing from two decades of expertise in cultivating high-performance leadership and operational teams, Geneous AI emerges as a frontrunner in transforming and accelerating organizational growth.

Advisory Board

Eric Gordon

CFO at Venture Growth Partners and Managing Partner at Translational Ventures, CEO at Atentiv Health, BioBehavioral Diagnostics

“In the realm of venture growth, strategic financial management is not just about numbers; it’s about nurturing innovation and fostering sustainable growth.”

Micheal Magliochetti

Operating Partner at Riverside Partners, President at Claros Diagnostics, Entrepreneur-in-Residence at Oxford Bioscience Partners

“Navigating the intersection of healthcare and entrepreneurship requires not only vision but also a relentless pursuit of technological advancements that redefine patient care.”

Nirmal Keshava

VP Data Sciences and Innovation at Cerevel Therapeutics, Founder of Constellation Analytics, Head of AI at BioXcel Therapeutic

“Harnessing the power of data and artificial intelligence in healthcare isn’t just about predicting outcomes; it’s about unlocking transformative insights that can revolutionize treatment paradigms.”

Velumani Pillai

In today’s digital age, the convergence of data and healthcare technology isn’t just inevitable; it’s imperative for driving personalized, patient-centric care on a global scale.

“In today’s digital age, the convergence of data and healthcare technology isn’t just inevitable; it’s imperative for driving personalized, patient-centric care on a global scale.”

Yali Li

CDO, Function Oncology, VP Biostatistics and Informatics, Thrive

“Geneous AI represents a paradigm shift in oncology, empowering us to unravel complex biological data with unprecedented speed and accuracy, ultimately driving innovative solutions in cancer care.”

Bill Enright

CEO, Barinthus Therapeutics

“Geneous AI embodies the cutting edge of bioinformatics, revolutionizing our approach to drug discovery and development. Its capabilities are poised to redefine therapeutic landscapes and enhance patient outcomes.”

Peter Johnson

CIO, Beth Israel Lahey Health, CIO/SVP, Dartmouth-Hitchcock Medical Center

“In the realm of healthcare informatics, Geneous AI stands as a beacon of progress, offering transformative insights into patient data and accelerating the pace of personalized medicine, shaping the future of healthcare delivery.”